NCT04808596 Pulmonary Hypertension Biorepository and Registry
| NCT ID | NCT04808596 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Kansas Medical Center |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2020-08-10 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2020-08-10 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
Eligibility Criteria
Inclusion Criteria: 1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP) 2. The participant has a diagnosis of pulmonary hypertension confirmed by right heart catheterization 3. Patient is ≥ 18 years of age or older Exclusion Criteria: 1. Participant declines to participate (living patients only) 2. Participant is unable to provide informed consent (living patients only)
Contact & Investigator
Leslie A Spikes, MD
PRINCIPAL INVESTIGATOR
Assistant Professor of Medicine
Frequently Asked Questions
Who can join the NCT04808596 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04808596 currently recruiting?
Yes, NCT04808596 is actively recruiting participants. Contact the research team at lboccardi@kumc.edu for enrollment information.
Where is the NCT04808596 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT04808596 clinical trial?
NCT04808596 is sponsored by University of Kansas Medical Center. The principal investigator is Leslie A Spikes, MD at Assistant Professor of Medicine. The trial plans to enroll 300 participants.